Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells

Molecular targeted therapy has shown promise as a treatment for advanced hepatocellular carcinoma (HCC). Sorafenib, a multikinase inhibitor, recently received FDA approval for the treatment of advanced HCC. However, although sorafenib is well tolerated, concern for its safety has been expressed. Cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Cervello, Melchiorre, Bachvarov, Dimcho, Lampiasi, Nadia, Cusimano, Antonella, Azzolina, Antonina, McCubrey, James A., Montalto, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680460/
https://www.ncbi.nlm.nih.gov/pubmed/23776502
http://dx.doi.org/10.1371/journal.pone.0065569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680460/
https://www.ncbi.nlm.nih.gov/pubmed/23776502
http://dx.doi.org/10.1371/journal.pone.0065569

Ejemplares similares